Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-week phase 2 study of ARRY-438162 in rheumatoid arthritis patients with inadequate response to methotrexate
2007-007859-14Phase 2Completed
- Sponsor
- Array BioPharma
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of binimetinib in rheumatoid arthritis (RA) (4 arms), sponsored by Array BioPharma. Primary endpoint: ACR20 response at Week 12. Started Jan 2008; status: completed.
02
Drugs
binimetinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2007-007859-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007859-14.